
AMR: Novo Holdings funds companies with €18m
"Three additional investments into companies developing innovative novel anti-infective therapies were made in late 2018", Novo Holdings...

EC advisors call for update of GM legislation
The seven advisiors of the EU Commission (SAM) call on the European Commission (EC) to revise the existing GMO directive 2001/18/EC because the...

Investors pool €27m for new Proteomics tech
Developed at the University of Cambridge, Fluidic Analytics’ platform is designed to give insights into the way that proteins fold, aggregate and...

Adrenomed bags €24m in growth financing
The company said it will use the proceeds to advance clinical testing of adrecizumab, the companies first-in-class antibody targeting endothelial...

First immunotolerant allogenic cell transplants revealed
Though induced pluripotent stem cells (iPSCs) provide a cell source that propagates unlimited and can be differentiated in any tissue of the body,...

Argenx in US$1.6bn deal with J&J affiliate Janssen
Under the deal, Janssen will pay US$300m in cash to argenx for the global commercialisation rights of cusatuzumab, currently developed in in AML, MDS...

IMI launches €80m call
The new call of the joint undertaking of the European Commission and the Big Pharma federation EFPIA puts new open access tools for drug development,...